Search Results

You are looking at 31 - 40 of 173 items for :

  • Refine by Access: All x
Clear All
Full access

BPI22-010: Applying FRAME to Code Modifications to a Community-Based Educational Intervention and Lung Cancer Screening Protocols Amidst the Covid-19 Pandemic

Sydney Beache, Aimee James, Graham Colditz, and Courtney Harriss

, covering screening eligibility and follow-up guidelines, navigating screening referral, and smoking cessation. Screening increased 18% following implementation of I-STEP. The COVID-19 pandemic prompted unforeseen changes to the healthcare landscape, wherein

Full access

CLO22-068: An Assessment of Extended Pembrolizumab Dosing and Outcomes in Advanced Non-Small Cell Lung Cancer Patients During the COVID-19 Pandemic

Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, Andrea S. Fung, and Pierre-Olivier Gaudreau

Background : The COVID-19 pandemic led to Cancer Care Ontario’s approval of extended dosing (ED) of pembrolizumab in the management of metastatic non-small cell lung cancer (mNSCLC) as a means of reducing the risk of exposure through less visits

Full access

HSR22-147: Experiences of Patients (pts) With Metastatic Breast Cancer (mBC) During the COVID-19 Pandemic in the United States: Results of the Rethink Access to Care & Treatment (REACT) Survey

Neil Iyengar, Clay Williams, Michael Rogan, Laurie Campbell, Shirley Mertz, Jeremy Block, Maria Ebling, Connie Chen, Justin Doan, Samantha K. Kurosky, and Timothy Pluard

Background : Significant changes were made in healthcare treatment (tx), safety standards, and protocols during the COVID-19 pandemic. mBC pts are particularly vulnerable to such changes, making it critical to understand their perspectives

Full access

Advancing Health Equity in Cancer-Related Distress: Lessons Learned From the COVID-19 Pandemic on Leveraging Digital Tools and Future Directions

Derek Falk and Bradley J. Zebrack

The COVID-19 pandemic has amplified the need for healthcare systems to integrate digital tools, including patient portals, telehealth, and electronic health records, to optimize whole-person cancer care. Pandemic protocols have limited and, in

Full access

Ensuring Diversity and Inclusion in Clinical Development by Leveraging Community Oncology Centers

Joshua Richter, Stephen J. Noga, and Robert Rifkin

oncology centers in relation to the ability to continue enrollment during COVID-19. Figure 1. Enrollment on US MM-6, 2017–2021. Enrollment was uninterrupted, nationwide, during the COVID-19 pandemic. US MM-6 provided an oral, accessible, continuous

Full access

Robust Response to Futibatinib in a Patient With Metastatic FGFR-Addicted Cholangiocarcinoma Previously Treated Using Pemigatinib

Anil K. Rengan and Crystal S. Denlinger

radiographic response at her first disease evaluation 2 months into treatment ( Figure 2 ). Figure 2. CT images at (A) treatment initiation, (B) CA 19-9 nadir, (C) treatment hold for COVID-19, and (D) disease progression. The patient’s course

Full access

Lasting Effects of COVID-19: Reimbursement Reform?

Margaret Tempero

Full access

Reimagining Professional Meetings: Another Lesson From COVID-19

Margaret Tempero

Full access

Health System Recruitment and Retention Strategies: A Plenary Session

Presented by: Rebecca L. Caires, Anne H. Gross, Todd A. Pickard, and Kristi Stiffler

Moderated by: Timothy Kubal

Defining the Problem The COVID-19 pandemic was undoubtedly an accelerator for departures in healthcare. Recruitment and retention have posed challenges in the field for years, but since the pandemic, strategies pertaining to these metrics have

Full access

Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center

Harrys A. Torres, Khalis Mustafayev, Ruston P. Juneau, Jessica P. Hwang, Lan Sun Wang, Georgios Angelidakis, Ernest Hawk, Bruno P. Granwehr, Eduardo Yepez Guevara, and Anita K. Ying

before study implementation to 34.4% during the last 6 months of the study period ( P <.001). The number of patients screened for HCV each month increased over time except during the peak of the COVID-19 pandemic ( Figure 2 ). Figure 1. Flow diagram